|
|
||||||||
1 Section of Medical Oncology, Departments of Internal Medicine and Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06520; 2 United States Biochemical, Cleveland, Ohio 44128; and 3 Abbott Diagnostics, Abbott Park, Illinois 60064
Previous studies indicated that uridine is
essentially cleared in a single pass through a rat liver and replaced
in a highly regulated manner by uridine formed presumably by de novo
synthesis. We report a cellular basis for the catabolic component of
this apparent paradox by dissociation of the liver with collagenase into two cell fractions, hepatocytes and a nonparenchymal cell population. Suspensions of the nonparenchymal cells rapidly cleave uridine to uracil, whereas in hepatocytes this activity was <5% of
that in nonparenchymal cells. Conversely, hepatocytes cause extensive
degradation of uracil to
-alanine. These differences correlate with
the uridine phosphorylase and dihydrouracil dehydrogenase activity in
cell-free extracts of each cell type. We have documented the existence
of a Na+-dependent,
nitrobenzylthioinosine-insensitive transport system for uridine in the
parenchymal cells (Michaelis constant 46 ± 5 µM) that achieves a
three- to fourfold concentration gradient in hepatocytes. A similar
system is present in the nonparenchymal cell population. In addition, a
highly specific and active
Na+-dependent transport system for
-alanine, the primary catabolic metabolite of uracil, has been
demonstrated in hepatocytes.
pyrimidines; metabolism; compartmentalization
This article has been cited by other articles:
![]() |
D. Zhang, D. Cao, R. Russell, and G. Pizzorno p53-dependent Suppression of Uridine Phosphorylase Gene Expression through Direct Promoter Interaction Cancer Res., September 1, 2001; 61(18): 6899 - 6905. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Cao, M. A. Nimmakayalu, F. Wang, D. Zhang, R. E. Handschumacher, P. Bray-Ward, and G. Pizzorno Genomic Structure, Chromosomal Mapping, and Promoter Region Analysis of Murine Uridine Phosphorylase Gene Cancer Res., October 1, 1999; 59(19): 4997 - 5001. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Adams, J. J. Leffert, D. J. Craig, T. Spector, and G. Pizzorno In Vivo Effect of 5-Ethynyluracil on 5-Fluorouracil Metabolism Determined by 19F Nuclear Magnetic Resonance Spectroscopy Cancer Res., January 1, 1999; 59(1): 122 - 127. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Liu, R. L. Russell, L. Beigelman, R. E. Handschumacher, and G. Pizzorno beta -Alanine and alpha -fluoro-beta -alanine concentrative transport in rat hepatocytes is mediated by GABA transporter GAT-2 Am J Physiol Gastrointest Liver Physiol, January 1, 1999; 276(1): G206 - G210. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |